This project will improve the diagnosis of high-risk coronary artery disease (CAD), which accounts for >7 million deaths each year worldwide. Individuals with diabetes have approximately a threefold increase in the risk of death from CAD. It often occurs when a blood vessel supplying the heart is suddenly blocked due to high-risk plaques. Existing technologies cannot accurately predict which plaques will become high-risk and cause heart attacks.
To enable accurate detection, a clinician-identified unmet need, we have developed a novel imaging device, building on a series of breakthroughs in 3D nano-printing, multimodal/hybrid imaging, and artificial intelligence.
Through this project, we will refine and test our device, which will allow doctors to more accurately detect high-risk plaques before they become life-threatening. This will help guide the care of patients to reduce their risk of having potentially fatal heart attacks and prevent those with low-risk plaques from undergoing unnecessary aggressive treatments.
TTRA Project: Devices
State: SA
Project Partners:
Project Lead: A/Prof Jiawen Li
TTRA Funding: $1,000,000.00
Co-Contribution: $1,000,000.00 cash; $168,862.86 in-kind
Project term: 1 July 2025 – 30 June 2027
LinkedIn Innovation Commercial – Uni Adelaide
